Press Releases for ATSI

Press Releases
ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
ATS Medical Announces Second Quarter 2009 Results
ATS Medical to Participate at Upcoming Investor Conferences
ATS Medical Announces Second Quarter 2009 Earnings Release Date and Conference Call
ATS Medical Announces First Use of the New ATS CryoMaze 10-S Probe
ATS Medical Announces FDA Clearance and First Implant of New ATS Simulus Semi-Rigid Annuloplasty Band
ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America
ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting
ATS Medical Announces FDA Clearance of the ATS Simulus Adjustable Annuloplasty Band
ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons
ATS Medical to Participate at Upcoming Investor Conferences
ATS Medical Announces Record First Quarter 2009 Results
ATS Medical Announces Record First Quarter 2009 Results
ATS Medical Appoints New Vice President of Marketing
ATS Medical Announces First Quarter 2009 Earnings Release Date and Conference Call
ATS Medical Announces Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve in Japan
Zacks Analyst Blog Highlights: Overseas Shipholding Group, Inc., Zoran Corp., ATS Medical, Inc., CarMax Group, and FedEx Corporation
ATS Medical Announces Fourth Quarter 2008 Results
ATS Medical Announces Fourth Quarter 2008 Earnings Release Date and Conference Call
ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis
ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting
ATS Medical Announces Formation of Cryoablation Surgical Advisory Board
ATS Medical to Participate at the 27th Annual J.P. Morgan Healthcare Conference
ATS Medical Announces $20 Million in Proceeds From a Private Equity Financing and Announces Resolution of Litigation
ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis
ATS Medical to Participate at the RBC Capital Markets Healthcare Conference
ATS Medical to Participate at the 20th Annual Piper Jaffray Health Care Conference
ATS Medical Announces First Commercial Implants of the ATS 3f Aortic Bioprosthesis in the United States
Zacks Bull and Bear of the Day Highlights: Avon Products, Huntington Bancshares, Ambac Financial, PetSmart and ATS Medical, Inc.
ATS Medical to Participate at the Rodman & Renshaw Annual Global Investment Conference
ATS Medical Announces Third Quarter Results
ATS Forcefield Anti-platelet Technology Continues to Demonstrate Positive Results
ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis
ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call
Dr. James Cox, Medical Director for ATS Medical, To Present at TCT Surgeon Session
ATS Medical to Participate at the Natixis Bleichroeder Second Annual Hidden Gems Conference
ATS Medical Announces US Launch of ATS CryoMaze Surgical Ablation Clamp
ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting
ATS Medical to Participate at the 2008 Thomas Weisel Partners Healthcare Conference
ATS Medical Announces CE Mark Regulatory Approval for ATS CryoMaze(TM)
ATS Medical to Participate at the Fourth Annual Noble Financial Equity Conference
ATS Medical to Participate at the 28th Annual Canaccord Adams Global Growth Conference
ATS Medical Announces Second Quarter Results
ATS Medical Appoints New Vice President of Operations
ATS Medical Announces Second Quarter 2008 Earnings Release Date and Conference Call
BeaconEquity.com Issues Technical Trade Alerts on Market Movers: GNAU, CHRS, NTRI, SCUR, ATSI, URRE
ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
Wall Street Media Presents Exclusive Videos from the Collins Stewart Fourth Annual Growth Conference
ATS Medical Expects Second Quarter Revenue of $16.7 to $16.9 Million
ATS Medical to Participate at the Fourth Annual Collins Stewart Growth Conference
ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve
ATS Medical to Participate at the Piper Jaffray Europe Conference
ATS Medical's Forcefield Technology Subject of American Society for Artificial Internal Organs Annual Conference Presentation
ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations
ATS Medical to Participate at the Rodman & Renshaw 5th Annual Global Healthcare Conference - Jun 1 2008 10:30AM
ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons - Jun 1 2008 10:30AM
ATS Medical Announces Record Quarterly Revenue and Gross Profit - Jun 1 2008 10:30AM
ATS Medical Announces First 'Frontiers in Cryoablation' Symposium
ATS Medical Announces First Quarter 2008 Earnings Release Date and Conference Call
ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis
ATS Medical Expects First Quarter Revenue of $14.6 to $14.8 Million